Customized TULSA-PRO Ablation Registry
NCT05001477
This study is recruiting at 5 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
This patient registry will capture data from patients who have been or who are undergoing the transurethral ultrasound ablation (TULSA) procedure as part of their routine clinical care. The registry will shed light on real-world outcomes of safety and efficacy of the procedure and understand how a patient's quality of life is affected throughout their follow-up and lifetime.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Prostate Cancer
- Prostate Adenocarcinoma
- Benign Prostatic Hyperplasia
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- Male
- Healthy volunteers
- Not accepted
- Sponsor
- Profound Medical Inc.
- Last updated on ClinicalTrials.gov
- November 6, 2024
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- RadNet's Liberty Pacific West Hills Facility · West Hills, CA
Florida · 1
- Mayo Clinic Jacksonville · Jacksonville, FL
Pennsylvania · 1
- Wellspan Health · York, PA
Texas · 2
- University of Texas Southwestern Medical Center · Dallas, TX
- Urology Place · San Antonio, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.